Myomo, Inc. Derivative Assets (Liabilities), at Fair Value, Net
Myomo, Inc. (MYO) had Derivative Assets (Liabilities), at Fair Value, Net of $558.20 thousand as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes
us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet · last filed 2026-05-07
- 2026-03-31: Derivative Assets (Liabilities), at Fair Value, Net $558.20K.
- 2025-12-31: Derivative Assets (Liabilities), at Fair Value, Net $135.50K.
| Period end | Derivative Assets (Liabilities), at Fair Value, Net |
|---|---|
| 2026-03-31 | $558.20K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $135.50K 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |